<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE QUARTERLY FINANCIAL STATEMENTS OF INHALE THERAPEUTICS SYSTEMS, INC., AS FILED ON FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2000. </LEGEND> <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-31-2000 <PERIOD-START> JAN-01-2000 <PERIOD-END> SEP-30-2000 <CASH> 93,095 <SECURITIES> 187,819 <RECEIVABLES> 1,942 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 288,644 <PP&E> 121,373 <DEPRECIATION> (19,901) <TOTAL-ASSETS> 420,325 <CURRENT-LIABILITIES> 21,519 <BONDS> 237,760 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 296,738 <OTHER-SE> (142,569) <TOTAL-LIABILITY-AND-EQUITY> 420,325 <SALES> 0 <TOTAL-REVENUES> 38,483 <CGS> 0 <TOTAL-COSTS> 0 <OTHER-EXPENSES> 86,785 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 24,183 <INCOME-PRETAX> (57,794) <INCOME-TAX> 0 <INCOME-CONTINUING> (57,794) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (57,794) <EPS-BASIC> (1.42) <EPS-DILUTED> (1.42)